Naloxone Hydrochloride Injection
Product Images NDC 51662-1239

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 51662-1239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of naloxone hydrochloride showing its molecular arrangement, including rings, hydroxyl groups, and the hydrochloride component indicated by HCl.*

FDA Label Image

Image (How Supplied Image)

An instructional diagram showing how to assemble and prepare a naloxone hydrochloride injection. It includes removing protective caps, aligning the vial needle with the stopper, threading the vial into the injector needle 3 half turns without pushing it in to avoid misalignment, and removing the needle cap and expelling air before injection.*

FDA Label Image

Syringe (1000430 76329 3369 01 Naloxone Syr)

Label for Naloxone Hydrochloride Injection, USP, 1 mg/mL strength, 2 mL vial. The label includes dosage information indicating 2 mg total per vial and 1 mg/mL concentration. It specifies routes of administration: intramuscular (I.M.), intravenous (I.V.), and subcutaneous (S.C.) single dose use. The labeler is HF Acquisition Co. LLC, DBA HealthFirst. A barcode and Rx Only designation are also visible.*

FDA Label Image

Box (1000430 76329 3369 01 Naloxone Syr Box)

Packaging label for NALOXONE HYDROCHLORIDE injection, USP 1 mg/mL, 2 mg per 2 mL strength, presenting a Luer-Jet Luer-Lock prefilled syringe. The label includes usage instructions, warnings, and manufacturer's information by INTERNATIONAL MEDICATION SYSTEMS, LIMITED. The label is for parenteral use with detailed syringe assembly directions and storage conditions.*

FDA Label Image

Serialized Label (51662 1239 1 Naloxone HCl 2)

NALOXONE HYDROCHLORIDE injection, USP 2 mg/2 mL carton by HF Acquisition Co. LLC, DBA HealthFirst. The label states it is single dose, contains no preservative, and should be stored at 25°C (77°F) with permitted temperature excursions. It is intended for intravenous, intramuscular, or subcutaneous use as an opioid antagonist, with usual dosage instructions provided in the insert.*

FDA Label Image

Pouch Labeling (51662123928 Naloxone Pouch Label)

Label for Naloxone Hydrochloride Injection USP 1 mg/mL with a strength of 2 mg per 2 mL syringe. The label displays NDC 51662-1239-2, lot number 12345, and expiration date 2001-03-01. It indicates the product is manufactured by HF Acquisition Co., LLC, Mukilteo, WA 98275, and includes usage and storage instructions along with a QR code at the bottom right.*

FDA Label Image

Rfid Label (51662 1239 3 Rfid)

Label on packaging for NALOXONE HYDROCHLORIDE injection 1 mg/mL by HF Acquisition Co. LLC, DBA HealthFirst. The label includes barcode data strings and instructions to see the manufacturer's insert. Distribution address is Mukilteo, WA 98275.*

FDA Label Image

Case Labeling (51662123935 Naloxone Case Label)

Label for Naloxone Hydrochloride Injection USP 1 mg/mL, containing 2 mg per 2 mL syringe, packaged as a box of 10. The label includes NDC 51662-1239-3, lot number 12345, and expiration date 2030-01-01. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.